Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Apr 6;187(7):1113-22.
doi: 10.1084/jem.187.7.1113.

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism

R T Gandhi  1 , B K Chen, S E Straus, J K Dale, M J Lenardo, D Baltimore
Affiliations

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism

R T Gandhi et al. J Exp Med. .

Abstract

The mechanism by which HIV-1 induces CD4(+) T cell death is not known. A fundamental issue is whether HIV-1 primarily induces direct killing of infected cells or indirectly causes death of uninfected bystander cells. This question was studied using a reporter virus system in which infected cells are marked with the cell surface protein placental alkaline phosphatase (PLAP). Infection by HIV-PLAP of peripheral blood mononuclear cells (PBMCs) and T cell lines leads to rapid depletion of CD4(+) T cells and induction of apoptosis. The great majority of HIV-induced T cell death in vitro involves direct loss of infected cells rather than indirect effects on uninfected bystander cells. Because of its proposed role in HIV-induced cell death, we also examined the Fas (CD95/Apo1) pathway in killing of T cells by HIV-1. Infected PBMCs or CEM cells display no increase in surface Fas relative to uninfected cells. In addition, HIV-1 kills CEM and Jurkat T cells in the presence of a caspase inhibitor that completely blocks Fas-mediated apoptosis. HIV-1 also depletes CD4+ T cells in PBMCs from patients who have a genetically defective Fas pathway. These results suggest that HIV-1 induces direct apoptosis of infected cells and kills T cells by a Fas-independent mechanism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Genomic organization of HIV constructs. NL-PI is derived from NL43 and expresses all of the accessory genes of HIV-1. IRES indicates insertion of an internal ribosomal entry site (from encephalomyocarditis virus) which restores expression of nef in NL-PI. HXBnPLAP is derived from HXB-2D and does not express the accessory genes vpr, vpu and nef. Gray boxes indicate genes expressed by the virus; open boxes indicate genes that are not expressed.
Figure 1
Figure 1
Genomic organization of HIV constructs. NL-PI is derived from NL43 and expresses all of the accessory genes of HIV-1. IRES indicates insertion of an internal ribosomal entry site (from encephalomyocarditis virus) which restores expression of nef in NL-PI. HXBnPLAP is derived from HXB-2D and does not express the accessory genes vpr, vpu and nef. Gray boxes indicate genes expressed by the virus; open boxes indicate genes that are not expressed.
Figure 2
Figure 2
CD4+ T cell depletion after infection with HIV-1. (A) SupT1 and CEM cells were infected with either NL43 or NL-PI or mock-infected and the number of viable cells was determined by trypan blue exclusion on the indicated days after infection. (B) PBMCs from a normal donor were infected with different concentrations of NL43 (measured in nanograms per milliliter of p24) or mock-infected. Samples were stained daily for CD3, CD4, and CD8 and analyzed by flow cytometry. The percentage of CD4+ cells remaining on each day is plotted. Cells that were CD3+CD4−CD8− were considered to have downregulated CD4 and were included in the percentage of CD4+ T cells remaining. (C) CD4+ T cells were purified from a normal donor and infected with HXB2 or mock-infected. The number of viable cells was determined by trypan blue exclusion on the indicated days after infection. All experiments were performed at least three times and representative results are shown.
Figure 2
Figure 2
CD4+ T cell depletion after infection with HIV-1. (A) SupT1 and CEM cells were infected with either NL43 or NL-PI or mock-infected and the number of viable cells was determined by trypan blue exclusion on the indicated days after infection. (B) PBMCs from a normal donor were infected with different concentrations of NL43 (measured in nanograms per milliliter of p24) or mock-infected. Samples were stained daily for CD3, CD4, and CD8 and analyzed by flow cytometry. The percentage of CD4+ cells remaining on each day is plotted. Cells that were CD3+CD4−CD8− were considered to have downregulated CD4 and were included in the percentage of CD4+ T cells remaining. (C) CD4+ T cells were purified from a normal donor and infected with HXB2 or mock-infected. The number of viable cells was determined by trypan blue exclusion on the indicated days after infection. All experiments were performed at least three times and representative results are shown.
Figure 3
Figure 3
TUNEL assay on infected and uninfected CD4+ T cells. (A) CD4+ T cells from a normal donor were purified and infected with HXB2 or mock-infected. TUNEL assays were performed 3 and 5 d after infection. The TUNEL-positive gate was determined by analyzing each sample in parallel without TdT in the TUNEL reaction mix. (B) CEM and SupT1 cells were infected with NL43 or mock-infected and purified CD4+ T cells were infected with HXB2 or mock-infected. TUNEL assays were performed on days when the cell counts were declining. The percentage of TUNEL-positive cells is plotted for CEM, SupT1 (both day 6 after infection) and purified CD4+ T cells (day 5 after infection). These results are representative of three separate experiments.
Figure 4
Figure 4
Two-color flow cytometric analysis of cells for PLAP and TUNEL. CEM cells (A–C) and purified CD4+ T cells (D–F) were mock-infected or infected with NL-PI. CEM cells and purified CD4+ T cells were stained 4 and 5 d after infection, respectively, for PLAP and TUNEL. (A and D) uninfected cultures. (B and E) Infected cultures. (C and F) Infected cultures in which TdT was left out of the TUNEL reaction mix. The percentage of cells in each region is indicated in the corners of each plot. These results are representative of three separate experiments.
Figure 5
Figure 5
Two-color flow cytometric analysis of PBMC for Fas and PLAP. (A) Uninfected cells. (B) PBMCs on day 6 after infection with HXBnPLAP.
Figure 6
Figure 6
Sensitivity of CEM and SupT1 cells to anti-Fas antibody. Cells were incubated for 24 h in the presence of the indicated concentrations of mouse anti–human Fas IgM antibody (CH11). The percentage of apoptosis was assessed by staining the cells with propidium iodide and determining the fraction of cells that had hypodiploid DNA content.
Figure 7
Figure 7
The effect of the caspase inhibitor z-VAD-fmk on apoptosis induced by Fas and on killing of T cells by HIV-1. (A) Anti-Fas antibody (CH11) at 1 μg/ml was added to the indicated samples of CEM T cells that had been grown in the presence or absence of 50 μM of z-VAD-fmk. At 18 h after addition of anti-Fas antibody, the samples were analyzed for apoptosis by the TUNEL assay. (B) CEM T cells were infected with HXBnPLAP in the presence or absence of 50 μM z-VAD-fmk. Fresh z-VAD-fmk was added to the culture every 2 d. On the indicated days, equal sample volumes were counted for 1 min on a FACScan® and the number of cells with forward and side scatter characteristics consistent with viable cells was determined. This number in infected samples is plotted as a fraction of the number in the mock-infected culture.
Figure 8
Figure 8
Fraction of CD4+ T cells lost after HIV-1 infection of PBMCs from patients with ALPS and normal controls. PBMCs from the patients characterized in Table 1 were infected with 200 ng/ml p24 of NL-PI and samples were stained daily for CD4 and PLAP. The fraction of CD4+ cells loss compared with uninfected is 1 − (percentage of CD4+ cells in the infected sample/percentage of CD4+ cells in the uninfected sample). Cells that were PLAP+ and CD4lo were considered to be infected cells that had downmodulated CD4, and, thus, were included in the determination of CD4+ cells present in the sample.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and lymphocytes in HIV-1 infection. Nature. 1995;373:123–126. - PubMed
    1. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117–122. - PubMed
    1. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996;271:1582–1586. - PubMed
    1. Mellors JW, Rinaldo C, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167–1170. - PubMed
    1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993;57:183–289. - PMC - PubMed

Publication types